{"retracted":false,"update":{"timestamp":1457395200000,"doi":"10.1007/s11060-016-2100-6","type":"correction"},"doi":"10.1007/s11060-015-2025-5","journal":"Journal of Neuro-Oncology","publisher":"Springer Nature","title":"Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?"}
